| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.73e-08 | 118 | 167 | 10 | GO:0003774 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 6.31e-08 | 43 | 167 | 7 | GO:0030280 | |
| GeneOntologyMolecularFunction | actin filament binding | MYH1 MYH4 MYH10 MYO9A ACTN4 ACTN1 ACTN3 SHTN1 TLN1 MACF1 TLN2 MYO18B | 4.85e-07 | 227 | 167 | 12 | GO:0051015 |
| GeneOntologyMolecularFunction | structural molecule activity | KRT72 COL4A4 KRT4 KRT5 ANK3 MRPS18B KRT34 KRT81 KRT82 KRT83 KRT86 ACTN4 ACTN1 ACTN3 ODF2 ERBIN DST TLN1 KRT40 MACF1 TLN2 POTEJ | 5.39e-06 | 891 | 167 | 22 | GO:0005198 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.38e-05 | 130 | 167 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH1 FKBP15 MYH4 KIF6 MYH10 ANK3 CENPF MYO9A ACTN4 ACTN1 ACTN3 SHTN1 PPP2CB DST KIF15 TIMP2 PLEKHM2 TLN1 MACF1 TLN2 MYO18B GNB1 FKBP4 UNC13A | 1.53e-05 | 1099 | 167 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | MYH1 FKBP15 MYH4 MYH10 MYO9A ACTN4 ACTN1 ACTN3 SHTN1 DST TLN1 MACF1 TLN2 MYO18B | 5.24e-05 | 479 | 167 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | integrin binding | 1.15e-04 | 175 | 167 | 8 | GO:0005178 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.79e-04 | 38 | 167 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.01e-04 | 70 | 167 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.27e-04 | 18 | 167 | 3 | GO:0008569 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | KRT72 KRT4 KRT5 ARHGEF28 KRT34 KRT81 KRT82 KRT83 KRT86 ERBIN DST KRT40 MACF1 | 1.36e-12 | 99 | 167 | 13 | GO:0045104 |
| GeneOntologyBiologicalProcess | intermediate filament-based process | KRT72 KRT4 KRT5 ARHGEF28 KRT34 KRT81 KRT82 KRT83 KRT86 ERBIN DST KRT40 MACF1 | 1.55e-12 | 100 | 167 | 13 | GO:0045103 |
| GeneOntologyBiologicalProcess | intermediate filament organization | 9.57e-09 | 75 | 167 | 9 | GO:0045109 | |
| GeneOntologyBiologicalProcess | keratinization | 6.82e-06 | 87 | 167 | 7 | GO:0031424 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT72 KRT4 KRT5 MYH10 RAP1GDS1 KRT34 KRT81 KRT82 KRT83 KRT86 BAG4 ACTN4 ACTN1 SHTN1 WASHC2A FURIN KRT40 PDE4DIP FKBP4 PCM1 SMAD3 | 3.21e-05 | 957 | 167 | 21 | GO:0097435 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT72 COL4A4 MYH1 KRT4 KRT5 MYH4 KIF6 MYH10 ANK3 MYO9A KRT34 KRT81 KRT82 KRT83 KRT86 ACTN4 ACTN1 ACTN3 ODF2 SHTN1 SPECC1 DNAH7 DST KIF15 DNAH17 KRT40 PDE4DIP MACF1 POTEJ MYO18B FKBP4 DNAH11 | 1.34e-09 | 1187 | 168 | 32 | GO:0099081 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT72 MYH1 KRT4 KRT5 MYH4 KIF6 MYH10 ANK3 MYO9A KRT34 KRT81 KRT82 KRT83 KRT86 ACTN4 ACTN1 ACTN3 ODF2 SHTN1 SPECC1 DNAH7 DST KIF15 DNAH17 KRT40 PDE4DIP MACF1 POTEJ MYO18B FKBP4 DNAH11 | 4.58e-09 | 1179 | 168 | 31 | GO:0099512 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT72 KRT4 KRT5 KIF6 MYO9A KRT34 KRT81 KRT82 KRT83 KRT86 ACTN1 ACTN3 ODF2 SHTN1 SPECC1 DNAH7 DST KIF15 DNAH17 KRT40 PDE4DIP MACF1 POTEJ MYO18B FKBP4 DNAH11 | 1.43e-08 | 899 | 168 | 26 | GO:0099513 |
| GeneOntologyCellularComponent | intermediate filament | KRT72 KRT4 KRT5 KRT34 KRT81 KRT82 KRT83 KRT86 DST KRT40 MACF1 | 2.36e-06 | 227 | 168 | 11 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRT72 KRT4 KRT5 KRT34 KRT81 KRT82 KRT83 KRT86 DST KRT40 MACF1 | 9.60e-06 | 263 | 168 | 11 | GO:0045111 |
| GeneOntologyCellularComponent | keratin filament | 1.34e-05 | 97 | 168 | 7 | GO:0045095 | |
| GeneOntologyCellularComponent | myosin filament | 4.46e-05 | 25 | 168 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 FKBP15 MYH4 MYH10 MYO9A ACTN4 ACTN1 ACTN3 SPECC1 DST MACF1 TLN2 POTEJ MYO18B IQCG | 6.67e-05 | 576 | 168 | 15 | GO:0015629 |
| GeneOntologyCellularComponent | myosin II complex | 7.09e-05 | 28 | 168 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 1.11e-04 | 59 | 168 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | intercalated disc | 2.19e-04 | 68 | 168 | 5 | GO:0014704 | |
| GeneOntologyCellularComponent | myofibril | 3.76e-04 | 273 | 168 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | pseudopodium | 3.81e-04 | 18 | 168 | 3 | GO:0031143 | |
| GeneOntologyCellularComponent | microtubule organizing center | HMBOX1 FAM184A AHI1 CENPF UBR4 CENPU CCDC178 ODF2 SPECC1 TBC1D31 KIF15 TIMP2 CEP112 PDE4DIP NLRC5 PIK3R5 UVRAG PCM1 | 4.45e-04 | 919 | 168 | 18 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | HMBOX1 FAM184A AHI1 CENPF UBR4 CENPU ODF2 TBC1D31 KIF15 TIMP2 CEP112 PDE4DIP NLRC5 PIK3R5 UVRAG PCM1 | 4.96e-04 | 770 | 168 | 16 | GO:0005813 |
| GeneOntologyCellularComponent | contractile muscle fiber | 5.82e-04 | 290 | 168 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | sarcomere | 9.38e-04 | 249 | 168 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 9.74e-04 | 94 | 168 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | actin filament | 1.18e-03 | 146 | 168 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | Z disc | 1.41e-03 | 151 | 168 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.95e-03 | 161 | 168 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | I band | 2.27e-03 | 166 | 168 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | cilium | AHI1 CENPF TCP11 CCDC178 ODF2 DNAH7 TBC1D31 TIMP2 DNAH17 GNB1 USP48 TCTN1 PCM1 PMFBP1 DNAH11 IQCG | 2.45e-03 | 898 | 168 | 16 | GO:0005929 |
| GeneOntologyCellularComponent | ciliary transition fiber | 2.77e-03 | 10 | 168 | 2 | GO:0097539 | |
| HumanPheno | Abnormal perifollicular morphology | 8.62e-08 | 6 | 46 | 4 | HP:0031285 | |
| HumanPheno | Perifollicular hyperkeratosis | 2.74e-06 | 4 | 46 | 3 | HP:0007468 | |
| HumanPheno | Keratosis pilaris | 1.69e-05 | 37 | 46 | 5 | HP:0032152 | |
| HumanPheno | Nail dystrophy | 6.27e-05 | 156 | 46 | 8 | HP:0008404 | |
| HumanPheno | Blotching pigmentation of the skin | 7.98e-05 | 2 | 46 | 2 | HP:0007610 | |
| Domain | Keratin_II | 1.70e-09 | 26 | 160 | 7 | IPR003054 | |
| Domain | IF | 1.06e-08 | 72 | 160 | 9 | PS00226 | |
| Domain | Filament | 1.20e-08 | 73 | 160 | 9 | PF00038 | |
| Domain | IF | 1.73e-08 | 76 | 160 | 9 | IPR001664 | |
| Domain | Keratin_2_head | 4.26e-08 | 24 | 160 | 6 | IPR032444 | |
| Domain | Keratin_2_head | 4.26e-08 | 24 | 160 | 6 | PF16208 | |
| Domain | Intermediate_filament_CS | 6.32e-08 | 63 | 160 | 8 | IPR018039 | |
| Domain | Spectrin | 1.29e-06 | 23 | 160 | 5 | PF00435 | |
| Domain | ACTININ_2 | 1.29e-06 | 23 | 160 | 5 | PS00020 | |
| Domain | ACTININ_1 | 1.29e-06 | 23 | 160 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.29e-06 | 23 | 160 | 5 | IPR001589 | |
| Domain | Filament | 2.49e-06 | 71 | 160 | 7 | SM01391 | |
| Domain | Spectrin_repeat | 4.36e-06 | 29 | 160 | 5 | IPR002017 | |
| Domain | SPEC | 7.24e-06 | 32 | 160 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 7.24e-06 | 32 | 160 | 5 | IPR018159 | |
| Domain | EFhand_Ca_insen | 1.21e-05 | 6 | 160 | 3 | PF08726 | |
| Domain | EF-hand_Ca_insen | 1.21e-05 | 6 | 160 | 3 | IPR014837 | |
| Domain | Myosin_head_motor_dom | 1.73e-05 | 38 | 160 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.73e-05 | 38 | 160 | 5 | PS51456 | |
| Domain | Myosin_head | 1.73e-05 | 38 | 160 | 5 | PF00063 | |
| Domain | MYSc | 1.73e-05 | 38 | 160 | 5 | SM00242 | |
| Domain | Myosin-like_IQ_dom | 1.82e-05 | 19 | 160 | 4 | IPR027401 | |
| Domain | - | 1.82e-05 | 19 | 160 | 4 | 4.10.270.10 | |
| Domain | CH | 1.96e-05 | 65 | 160 | 6 | SM00033 | |
| Domain | CH | 3.00e-05 | 70 | 160 | 6 | PF00307 | |
| Domain | IQ | 3.25e-05 | 71 | 160 | 6 | PF00612 | |
| Domain | - | 3.25e-05 | 71 | 160 | 6 | 1.10.418.10 | |
| Domain | CH | 3.81e-05 | 73 | 160 | 6 | PS50021 | |
| Domain | CH-domain | 4.45e-05 | 75 | 160 | 6 | IPR001715 | |
| Domain | IQ | 6.87e-05 | 81 | 160 | 6 | SM00015 | |
| Domain | - | 7.29e-05 | 2 | 160 | 2 | 1.20.1420.10 | |
| Domain | FAM209 | 7.29e-05 | 2 | 160 | 2 | PF15206 | |
| Domain | VBS | 7.29e-05 | 2 | 160 | 2 | PF08913 | |
| Domain | Vinculin-bd_dom | 7.29e-05 | 2 | 160 | 2 | IPR015009 | |
| Domain | Talin_cent | 7.29e-05 | 2 | 160 | 2 | IPR015224 | |
| Domain | FAM209 | 7.29e-05 | 2 | 160 | 2 | IPR027943 | |
| Domain | Talin_middle | 7.29e-05 | 2 | 160 | 2 | PF09141 | |
| Domain | IQ_motif_EF-hand-BS | 1.24e-04 | 90 | 160 | 6 | IPR000048 | |
| Domain | IQ | 1.48e-04 | 93 | 160 | 6 | PS50096 | |
| Domain | Talin-1 | 2.18e-04 | 3 | 160 | 2 | IPR015710 | |
| Domain | Myosin_N | 2.60e-04 | 15 | 160 | 3 | PF02736 | |
| Domain | Myosin_N | 2.60e-04 | 15 | 160 | 3 | IPR004009 | |
| Domain | ILWEQ_dom | 4.33e-04 | 4 | 160 | 2 | IPR002558 | |
| Domain | ILWEQ | 4.33e-04 | 4 | 160 | 2 | SM00307 | |
| Domain | FERM_f0 | 4.33e-04 | 4 | 160 | 2 | PF16511 | |
| Domain | ILWEQ | 4.33e-04 | 4 | 160 | 2 | PD011820 | |
| Domain | - | 4.33e-04 | 4 | 160 | 2 | 1.20.1410.10 | |
| Domain | I_LWEQ | 4.33e-04 | 4 | 160 | 2 | PF01608 | |
| Domain | I_LWEQ | 4.33e-04 | 4 | 160 | 2 | PS50945 | |
| Domain | FERM_f0 | 4.33e-04 | 4 | 160 | 2 | IPR032425 | |
| Domain | Myosin_tail_1 | 4.58e-04 | 18 | 160 | 3 | PF01576 | |
| Domain | Myosin_tail | 4.58e-04 | 18 | 160 | 3 | IPR002928 | |
| Domain | Keratin_I | 5.39e-04 | 44 | 160 | 4 | IPR002957 | |
| Domain | Chemokine-like_FAM19A2 | 7.17e-04 | 5 | 160 | 2 | IPR020350 | |
| Domain | Chemokine-like_2FAM19A2 | 7.17e-04 | 5 | 160 | 2 | PD298472 | |
| Domain | TAFA | 7.17e-04 | 5 | 160 | 2 | PF12020 | |
| Domain | - | 1.07e-03 | 6 | 160 | 2 | 3.90.1290.10 | |
| Domain | GAR | 1.07e-03 | 6 | 160 | 2 | PS51460 | |
| Domain | GAS2 | 1.07e-03 | 6 | 160 | 2 | PF02187 | |
| Domain | DUF3398 | 1.07e-03 | 6 | 160 | 2 | PF11878 | |
| Domain | - | 1.07e-03 | 6 | 160 | 2 | 3.30.920.20 | |
| Domain | DOCK_C/D_N | 1.07e-03 | 6 | 160 | 2 | IPR021816 | |
| Domain | GAS_dom | 1.07e-03 | 6 | 160 | 2 | IPR003108 | |
| Domain | GAS2 | 1.07e-03 | 6 | 160 | 2 | SM00243 | |
| Domain | ANK | 1.47e-03 | 251 | 160 | 8 | SM00248 | |
| Domain | Vinculin/catenin | 1.49e-03 | 7 | 160 | 2 | IPR006077 | |
| Domain | Plectin | 1.49e-03 | 7 | 160 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.49e-03 | 7 | 160 | 2 | IPR001101 | |
| Domain | PLEC | 1.49e-03 | 7 | 160 | 2 | SM00250 | |
| Domain | ANK_REPEAT | 1.55e-03 | 253 | 160 | 8 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.58e-03 | 254 | 160 | 8 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.58e-03 | 254 | 160 | 8 | PS50297 | |
| Domain | Ankyrin_rpt | 1.92e-03 | 262 | 160 | 8 | IPR002110 | |
| Domain | EF-hand_1 | 2.00e-03 | 152 | 160 | 6 | PF00036 | |
| Domain | EFh | 2.42e-03 | 158 | 160 | 6 | SM00054 | |
| Domain | Ank | 3.55e-03 | 228 | 160 | 7 | PF00023 | |
| Domain | DHR-1_domain | 3.81e-03 | 11 | 160 | 2 | IPR027007 | |
| Domain | DHR_2 | 3.81e-03 | 11 | 160 | 2 | PS51651 | |
| Domain | DHR_1 | 3.81e-03 | 11 | 160 | 2 | PS51650 | |
| Domain | DHR-2 | 3.81e-03 | 11 | 160 | 2 | PF06920 | |
| Domain | DOCK | 3.81e-03 | 11 | 160 | 2 | IPR026791 | |
| Domain | DOCK_C | 3.81e-03 | 11 | 160 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 3.81e-03 | 11 | 160 | 2 | PF14429 | |
| Domain | DHR-2 | 3.81e-03 | 11 | 160 | 2 | IPR027357 | |
| Domain | UBIQUITIN_1 | 3.87e-03 | 37 | 160 | 3 | PS00299 | |
| Domain | EF_hand_dom | 3.91e-03 | 232 | 160 | 7 | IPR002048 | |
| Domain | EF_Hand_1_Ca_BS | 4.01e-03 | 175 | 160 | 6 | IPR018247 | |
| Domain | Ubiquitin-rel_dom | 5.12e-03 | 184 | 160 | 6 | IPR029071 | |
| Domain | bZIP_Maf | 5.35e-03 | 13 | 160 | 2 | IPR004826 | |
| Domain | bZIP_Maf | 5.35e-03 | 13 | 160 | 2 | PF03131 | |
| Domain | - | 5.60e-03 | 248 | 160 | 7 | 1.25.40.20 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.20e-03 | 14 | 160 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 6.20e-03 | 14 | 160 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.20e-03 | 14 | 160 | 2 | IPR013602 | |
| Domain | DHC_N2 | 6.20e-03 | 14 | 160 | 2 | PF08393 | |
| Domain | IRS | 6.20e-03 | 14 | 160 | 2 | PF02174 | |
| Domain | IRS_PTB | 6.20e-03 | 14 | 160 | 2 | IPR002404 | |
| Domain | MT | 6.20e-03 | 14 | 160 | 2 | PF12777 | |
| Domain | AAA_8 | 6.20e-03 | 14 | 160 | 2 | PF12780 | |
| Domain | P-loop_NTPase | MYH1 MYH4 KIF6 MYH10 MYO9A GIMAP7 DNAH7 KIF15 NLRC5 MYO18B CDC6 RAB4A CARD14 AGAP2 DNAH11 | 6.28e-03 | 848 | 160 | 15 | IPR027417 |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 4.74e-08 | 87 | 119 | 9 | MM15351 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.33e-07 | 129 | 119 | 10 | M27649 | |
| Pathway | REACTOME_KERATINIZATION | 5.78e-06 | 153 | 119 | 9 | MM15343 | |
| Pathway | REACTOME_KERATINIZATION | 1.50e-05 | 217 | 119 | 10 | M27640 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRT72 COL4A4 KRT4 KRT5 ARHGEF28 KRT34 KRT81 KRT82 KRT83 KRT86 DARS1 TLN1 KRT40 CD72 SMAD3 | 2.09e-05 | 502 | 119 | 15 | MM14537 |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 1.12e-04 | 30 | 119 | 4 | M47724 | |
| Pathway | KEGG_TIGHT_JUNCTION | 1.26e-04 | 132 | 119 | 7 | M11355 | |
| Pathway | BIOCARTA_UCALPAIN_PATHWAY | 1.99e-04 | 14 | 119 | 3 | M13143 | |
| Pubmed | 2.70e-11 | 63 | 172 | 9 | 16831889 | ||
| Pubmed | MTA2 KRT72 KRT5 MYH10 RAP1GDS1 ANK3 ACAT1 MYO9A NAP1L1 DARS1 ACTN4 ACTN1 ACTN3 SPECC1 ERBIN PPP2CB DST TLN1 PDE4DIP MACF1 TLN2 EXOC1 GNB1 PRDX5 AP3D1 UNC13A PCM1 AGAP2 DNAH11 | 1.06e-10 | 1431 | 172 | 29 | 37142655 | |
| Pubmed | KRT72 MIX23 MYH1 KRT5 MYH4 MYH10 ACACB CENPF KRT34 UBR4 CCDC150 ACTN4 ACTN1 ACTN3 ODF2 ERBIN LARP7 PPP2CB DST TBC1D31 CEP112 KRT40 MACF1 POTEJ GNB1 AP3D1 AGAP2 | 2.78e-09 | 1442 | 172 | 27 | 35575683 | |
| Pubmed | RAP1GDS1 ANK3 KRT83 UBR4 BACH1 NAP1L1 DARS1 ACTN4 ACTN1 REV3L ODF2 SHTN1 SPECC1 MTMR10 FAN1 ZNF7 DST EHMT2 PDE4DIP MACF1 TLN2 EXOC1 GNB1 PCM1 AGAP2 | 5.41e-09 | 1285 | 172 | 25 | 35914814 | |
| Pubmed | KRT4 KRT5 MYH10 KRT34 KRT81 KRT82 KRT83 KRT86 UBR4 DARS1 ACTN4 ACTN1 | 1.00e-08 | 266 | 172 | 12 | 19380743 | |
| Pubmed | Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. | 1.17e-08 | 16 | 172 | 5 | 12399393 | |
| Pubmed | Comprehensive analysis of keratin gene clusters in humans and rodents. | 1.17e-08 | 16 | 172 | 5 | 15085952 | |
| Pubmed | 3.98e-08 | 8 | 172 | 4 | 12475935 | ||
| Pubmed | 3.98e-08 | 8 | 172 | 4 | 11381084 | ||
| Pubmed | FKBP15 MYH10 KCNH7 ACACB ANK3 ACAT1 DOCK9 UBR4 BACH1 DARS1 ACTN4 WASHC2A ERBIN PDE4DIP MACF1 TLN2 EXOC1 PRDX5 TMCC1 UNC13A PCM1 AGAP2 | 5.53e-08 | 1139 | 172 | 22 | 36417873 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 5.84e-08 | 197 | 172 | 10 | 20811636 | |
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 36515178 | ||
| Pubmed | Novel KRT83 and KRT86 mutations associated with monilethrix. | 1.19e-07 | 3 | 172 | 3 | 25557232 | |
| Pubmed | α-Actinin-3 deficiency is associated with reduced bone mass in human and mouse. | 1.19e-07 | 3 | 172 | 3 | 21784188 | |
| Pubmed | Structure and site of expression of a murine type II hair keratin. | 1.19e-07 | 3 | 172 | 3 | 1372089 | |
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 1712823 | ||
| Pubmed | EXOSC10 DOCK9 NAP1L1 ACTN4 ACTN3 DST EHMT2 TLN1 PDE4DIP MACF1 EXOC1 NOCT MYO18B SMAD3 | 2.09e-07 | 497 | 172 | 14 | 23414517 | |
| Pubmed | Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain. | 2.77e-07 | 12 | 172 | 4 | 10692104 | |
| Pubmed | FKBP15 MYH10 ANK3 CENPF ZNF618 UBR4 SHTN1 ERBIN PPP2CB DST KIF15 EHMT2 PDE4DIP MACF1 TLN2 GNB1 UNC13A PCM1 AGAP2 | 3.47e-07 | 963 | 172 | 19 | 28671696 | |
| Pubmed | DNAJB12 FAM184A EXOSC10 ANK3 MRPS18B UBR4 BAG4 BACH1 TIMMDC1 WASHC2A ERBIN LARP7 BRAP LIFR TBC1D31 EHMT2 TLN1 MACF1 USP48 TMCC1 AP3D1 FKBP4 ATPAF1 PCM1 | 3.58e-07 | 1487 | 172 | 24 | 33957083 | |
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 1629252 | ||
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 12547197 | ||
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 16807302 | ||
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 15797458 | ||
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 15988023 | ||
| Pubmed | 5.11e-07 | 191 | 172 | 9 | 33762435 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MTA2 KRT5 EXOSC10 ACAT1 CENPF KRT82 KRT86 NAP1L1 DARS1 ACTN4 ACTN1 SPECC1 DST TLN1 MACF1 GNB1 HEATR5B FKBP4 PCM1 | 8.68e-07 | 1024 | 172 | 19 | 24711643 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT72 KRT4 KRT5 MYH10 AHI1 KRT82 KRT86 HLA-G NAP1L1 ACTN4 ACTN1 EXOC1 TCTN1 PCM1 | 9.42e-07 | 564 | 172 | 14 | 21565611 |
| Pubmed | MTA2 EXOSC10 MYH10 ACAT1 CENPF UBR4 NAP1L1 ACTN4 ACTN1 LARP7 DST TLN1 MACF1 FKBP4 PCM1 | 9.99e-07 | 653 | 172 | 15 | 22586326 | |
| Pubmed | Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. | 1.18e-06 | 5 | 172 | 3 | 15841212 | |
| Pubmed | The adenosine A2A receptor interacts with the actin-binding protein alpha-actinin. | 1.18e-06 | 5 | 172 | 3 | 12837758 | |
| Pubmed | 1.18e-06 | 5 | 172 | 3 | 19943616 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MTA2 MIX23 EXOSC10 MYH10 GPX8 MRPS18B NAP1L1 ACTN4 ACTN1 CCDC144CP PPP2CB TLN1 MACF1 TLN2 GNB1 AP3D1 FKBP4 | 1.18e-06 | 847 | 172 | 17 | 35235311 |
| Pubmed | MTA2 DNAJB12 FKBP15 KRT5 EXOSC10 DOCK9 UBR4 HLA-G NAP1L1 DOCK10 DARS1 ADAM10 KIF15 FURIN EXOC1 HEATR5B AP3D1 PCM1 AGAP2 GNPAT | 1.51e-06 | 1168 | 172 | 20 | 19946888 | |
| Pubmed | MTA2 MYH10 CENPF NAP1L1 DARS1 ACTN4 SHTN1 WASHC2A LARP7 DST TLN1 RPRD2 POTEJ | 1.60e-06 | 506 | 172 | 13 | 30890647 | |
| Pubmed | 2.35e-06 | 6 | 172 | 3 | 18425115 | ||
| Pubmed | 2.35e-06 | 6 | 172 | 3 | 22693585 | ||
| Pubmed | 2.35e-06 | 6 | 172 | 3 | 15944823 | ||
| Pubmed | 2.35e-06 | 6 | 172 | 3 | 17171436 | ||
| Pubmed | 2.63e-06 | 20 | 172 | 4 | 21689717 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MTA2 FKBP15 EXOSC10 MYH10 ACACB NAP1L1 DARS1 SHTN1 ERBIN BRAP DST TLN1 MACF1 RPRD2 AP3D1 FKBP4 PCM1 | 4.36e-06 | 934 | 172 | 17 | 33916271 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MTA2 KRT5 EXOSC10 MYH10 ANK3 MRPS18B UBR4 NAP1L1 DARS1 ACTN4 ACTN1 SHTN1 DST TLN1 MACF1 GNB1 PRDX5 AP3D1 FKBP4 | 4.64e-06 | 1149 | 172 | 19 | 35446349 |
| Pubmed | MYH1 FKBP15 KRT5 MYH4 ANK3 MYO9A UBR4 BAG4 NAP1L1 DARS1 ACTN4 ACTN1 DST TLN1 MACF1 FKBP4 | 5.09e-06 | 844 | 172 | 16 | 25963833 | |
| Pubmed | 5.13e-06 | 322 | 172 | 10 | 26514267 | ||
| Pubmed | KRT5 MYH10 RAP1GDS1 ANK3 MYO9A ACTN4 ACTN1 ERBIN ZGPAT DST MACF1 ZBTB18 | 6.09e-06 | 486 | 172 | 12 | 20936779 | |
| Pubmed | KRT5 MYH10 KRT34 KRT81 KRT86 DARS1 ACTN4 ACTN1 SPECC1 TLN1 MACF1 AP3D1 | 6.35e-06 | 488 | 172 | 12 | 31324722 | |
| Pubmed | FKBP15 MYH10 DOCK9 DOCK10 ZSWIM6 WASHC2A ERBIN PLEKHM2 TLN1 PDE4DIP MACF1 | 6.45e-06 | 407 | 172 | 11 | 12693553 | |
| Pubmed | CHAP is a newly identified Z-disc protein essential for heart and skeletal muscle function. | 6.54e-06 | 8 | 172 | 3 | 20215401 | |
| Pubmed | Mice deficient in alpha-actinin-4 have severe glomerular disease. | 6.54e-06 | 8 | 172 | 3 | 12782671 | |
| Pubmed | 8.60e-06 | 96 | 172 | 6 | 23580065 | ||
| Pubmed | Insights into the Role of a Cardiomyopathy-Causing Genetic Variant in ACTN2. | 9.28e-06 | 27 | 172 | 4 | 36899856 | |
| Pubmed | 9.77e-06 | 9 | 172 | 3 | 11732910 | ||
| Pubmed | MTA2 DNAJB12 EXOSC10 MYH10 GPX8 MRPS18B UBR4 NAP1L1 RANBP6 ADAM10 SPECC1 ERBIN LARP7 LIFR DST TLN1 EXOC1 GNB1 PRDX5 AP3D1 PCM1 | 9.77e-06 | 1440 | 172 | 21 | 30833792 | |
| Pubmed | MYO9A ACTN4 ACTN1 SPECC1 ERBIN LIFR PPP2CB MACF1 GNB1 AP3D1 AGAP2 | 1.08e-05 | 430 | 172 | 11 | 32581705 | |
| Pubmed | 1.09e-05 | 151 | 172 | 7 | 17043677 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.29e-05 | 358 | 172 | 10 | 32460013 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MTA2 EXOSC10 MYH10 ACAT1 MYO9A GPX8 UBR4 NAP1L1 DOCK10 DARS1 ACTN4 ACTN1 ERBIN ZGPAT DST TLN1 ANKIB1 MACF1 EXOC1 AP3D1 | 1.33e-05 | 1353 | 172 | 20 | 29467282 |
| Pubmed | 1.35e-05 | 360 | 172 | 10 | 33111431 | ||
| Pubmed | Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology. | 1.39e-05 | 10 | 172 | 3 | 20368620 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MTA2 KRT72 KRT4 KRT5 EXOSC10 MYH10 CENPF MRPS18B NAP1L1 DARS1 ACTN4 ACTN1 SPECC1 PPP2CB DST GNB1 UHRF2 ATP4A FKBP4 | 1.63e-05 | 1257 | 172 | 19 | 36526897 |
| Pubmed | KRT72 MYH1 MYH10 NAP1L1 DARS1 ACTN4 ACTN1 HDAC7 DST TLN1 MACF1 MYO18B | 1.68e-05 | 538 | 172 | 12 | 28524877 | |
| Pubmed | 1.76e-05 | 225 | 172 | 8 | 12168954 | ||
| Pubmed | DNAJB12 MYH10 ANK3 UBR4 DARS1 SPECC1 ERBIN LARP7 DST TLN1 MACF1 FKBP4 PCM1 | 1.80e-05 | 634 | 172 | 13 | 34591612 | |
| Pubmed | MTA2 EXOSC10 ANK3 NAP1L1 ACTN1 SHTN1 ERBIN BRAP MTRF1 TLN1 RPRD2 PCM1 | 2.04e-05 | 549 | 172 | 12 | 38280479 | |
| Pubmed | 2.26e-05 | 233 | 172 | 8 | 37704626 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 11002341 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 19013433 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 23557398 | ||
| Pubmed | A missense mutation in the type II hair keratin hHb3 is associated with monilethrix. | 2.43e-05 | 2 | 172 | 2 | 15744029 | |
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 2.43e-05 | 2 | 172 | 2 | 9382868 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 11150240 | ||
| Pubmed | Leukotriene D4 up-regulates furin expression through CysLT1 receptor signaling. | 2.43e-05 | 2 | 172 | 2 | 18323532 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 20156433 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 9665406 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 9402962 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 26822056 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 34010028 | ||
| Pubmed | Extracellular rigidity sensing by talin isoform-specific mechanical linkages. | 2.43e-05 | 2 | 172 | 2 | 26523364 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 22398722 | ||
| Pubmed | Isoform-specific contributions of alpha-actinin to glioma cell mechanobiology. | 2.43e-05 | 2 | 172 | 2 | 20037648 | |
| Pubmed | HAMLET binding to α-actinin facilitates tumor cell detachment. | 2.43e-05 | 2 | 172 | 2 | 21408150 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 28797528 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 23454549 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 22306379 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 7684424 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 19822740 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 27240462 | ||
| Pubmed | Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice. | 2.43e-05 | 2 | 172 | 2 | 11744674 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | KRT5 FAM184A MYH10 ACACB NAP1L1 ACTN4 ODF2 WASHC2A DNAH7 TBC1D31 TLN1 NFX1 GNB1 FKBP4 PCM1 | 2.43e-05 | 853 | 172 | 15 | 28718761 |
| Pubmed | Phosphorylation of mouse LASP-1 on threonine 156 by cAMP- and cGMP-dependent protein kinase. | 2.53e-05 | 12 | 172 | 3 | 15465019 | |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 2.79e-05 | 118 | 172 | 6 | 27377895 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MTA2 DOCK9 UBR4 REV3L WASHC2A HDAC7 ZGPAT PPP2CB DST PLEKHM2 FURIN TLN1 NFX1 NLRC5 TLN2 UVRAG AP3D1 | 3.75e-05 | 1105 | 172 | 17 | 35748872 |
| Pubmed | Sequence and expression of murine type I hair keratins mHa2 and mHa3. | 4.16e-05 | 14 | 172 | 3 | 7514534 | |
| Pubmed | 4.16e-05 | 14 | 172 | 3 | 27184118 | ||
| Pubmed | 4.16e-05 | 14 | 172 | 3 | 24938781 | ||
| Pubmed | 4.16e-05 | 14 | 172 | 3 | 9373155 | ||
| Pubmed | MYH10 ANK3 KRT81 UBR4 RANBP6 ERBIN MTMR10 DST PDE4DIP MACF1 UHRF2 SMAD3 | 4.18e-05 | 591 | 172 | 12 | 15231748 | |
| Pubmed | 4.24e-05 | 330 | 172 | 9 | 32529326 | ||
| Pubmed | 4.42e-05 | 128 | 172 | 6 | 30995482 | ||
| Pubmed | 5.18e-05 | 15 | 172 | 3 | 11440986 | ||
| Interaction | KRT25 interactions | 1.42e-08 | 35 | 169 | 7 | int:KRT25 | |
| Interaction | KRT28 interactions | 1.60e-07 | 30 | 169 | 6 | int:KRT28 | |
| Interaction | KRT15 interactions | KRT72 KRT4 KRT5 AHI1 KRT81 KRT82 KRT83 KRT86 LARP7 ZGPAT PCM1 | 3.23e-07 | 178 | 169 | 11 | int:KRT15 |
| Interaction | KRT16 interactions | KRT72 KRT4 KRT5 AHI1 KRT81 KRT82 KRT83 KRT86 LARP7 TIMP2 PCM1 | 8.87e-07 | 197 | 169 | 11 | int:KRT16 |
| Interaction | KRT33B interactions | 1.15e-06 | 93 | 169 | 8 | int:KRT33B | |
| Interaction | KRT36 interactions | 2.89e-06 | 74 | 169 | 7 | int:KRT36 | |
| Interaction | KRT19 interactions | KRT72 KRT4 KRT5 KRT81 KRT82 KRT83 KRT86 LARP7 TBC1D31 KIF15 NFX1 PCM1 | 4.82e-06 | 282 | 169 | 12 | int:KRT19 |
| Interaction | KRT14 interactions | 5.25e-06 | 192 | 169 | 10 | int:KRT14 | |
| Interaction | MED4 interactions | FAM184A AHI1 ODF2 SHTN1 ERBIN LARP7 DST TBC1D31 POLR3E TLN1 KRT40 RPRD2 EXOC1 PCM1 SMAD3 | 6.21e-06 | 450 | 169 | 15 | int:MED4 |
| Interaction | ZNF329 interactions | 6.55e-06 | 32 | 169 | 5 | int:ZNF329 | |
| Interaction | KCTD13 interactions | MTA2 KRT72 KRT5 MYH10 RAP1GDS1 ANK3 ACAT1 MYO9A NAP1L1 DARS1 ACTN4 ACTN1 ACTN3 SPECC1 ERBIN PPP2CB DST TLN1 MACF1 TLN2 EXOC1 GNB1 PRDX5 AP3D1 UNC13A PCM1 AGAP2 DNAH11 | 1.39e-05 | 1394 | 169 | 28 | int:KCTD13 |
| Interaction | KRT73 interactions | 1.60e-05 | 64 | 169 | 6 | int:KRT73 | |
| Interaction | TSPAN33 interactions | 1.75e-05 | 65 | 169 | 6 | int:TSPAN33 | |
| Interaction | MRC2 interactions | 2.08e-05 | 67 | 169 | 6 | int:MRC2 | |
| Interaction | KRT37 interactions | 2.14e-05 | 100 | 169 | 7 | int:KRT37 | |
| Interaction | KRT35 interactions | 4.21e-05 | 111 | 169 | 7 | int:KRT35 | |
| Interaction | KRT6C interactions | 4.28e-05 | 76 | 169 | 6 | int:KRT6C | |
| Interaction | MYOZ1 interactions | 4.51e-05 | 47 | 169 | 5 | int:MYOZ1 | |
| Interaction | VPS33B interactions | 4.77e-05 | 199 | 169 | 9 | int:VPS33B | |
| Interaction | FGD5 interactions | 6.47e-05 | 207 | 169 | 9 | int:FGD5 | |
| Interaction | SPATA45 interactions | 6.99e-05 | 2 | 169 | 2 | int:SPATA45 | |
| Interaction | DIRAS3 interactions | RAP1GDS1 ANK3 BAG4 NAP1L1 SPECC1 DST PTPRG MACF1 FKBP4 ATPAF1 | 7.59e-05 | 262 | 169 | 10 | int:DIRAS3 |
| Interaction | KRT40 interactions | KRT72 MYH1 KRT4 KRT5 MYH4 MYO9A KRT81 KRT82 KRT83 KRT86 ZGPAT GUCD1 KRT40 | 7.87e-05 | 434 | 169 | 13 | int:KRT40 |
| Interaction | KRT81 interactions | 8.10e-05 | 53 | 169 | 5 | int:KRT81 | |
| Interaction | RTP5 interactions | 8.10e-05 | 53 | 169 | 5 | int:RTP5 | |
| Interaction | KRT24 interactions | 8.87e-05 | 54 | 169 | 5 | int:KRT24 | |
| Interaction | PIK3R5 interactions | 9.10e-05 | 11 | 169 | 3 | int:PIK3R5 | |
| Interaction | DSCAM interactions | 9.99e-05 | 171 | 169 | 8 | int:DSCAM | |
| Interaction | KRT38 interactions | 1.04e-04 | 172 | 169 | 8 | int:KRT38 | |
| Interaction | FHL1 interactions | 1.09e-04 | 129 | 169 | 7 | int:FHL1 | |
| Interaction | LCA5L interactions | 1.10e-04 | 30 | 169 | 4 | int:LCA5L | |
| Interaction | PACS1 interactions | 1.15e-04 | 57 | 169 | 5 | int:PACS1 | |
| Interaction | CDK18 interactions | 1.20e-04 | 131 | 169 | 7 | int:CDK18 | |
| Interaction | RGCC interactions | 1.21e-04 | 12 | 169 | 3 | int:RGCC | |
| Interaction | ATP23 interactions | 1.25e-04 | 58 | 169 | 5 | int:ATP23 | |
| Interaction | RABEP2 interactions | 1.33e-04 | 93 | 169 | 6 | int:RABEP2 | |
| Interaction | MTNR1B interactions | 1.45e-04 | 135 | 169 | 7 | int:MTNR1B | |
| Interaction | OMA1 interactions | 1.52e-04 | 136 | 169 | 7 | int:OMA1 | |
| Interaction | TRAF3IP1 interactions | 1.58e-04 | 96 | 169 | 6 | int:TRAF3IP1 | |
| Interaction | KRT77 interactions | 1.58e-04 | 96 | 169 | 6 | int:KRT77 | |
| Interaction | KRT4 interactions | 1.72e-04 | 62 | 169 | 5 | int:KRT4 | |
| Interaction | OFD1 interactions | FAM184A AHI1 KRT81 KRT83 KRT86 ODF2 WASHC2A TBC1D31 PLEKHM2 FKBP4 PCM1 | 1.73e-04 | 347 | 169 | 11 | int:OFD1 |
| Interaction | FAM9C interactions | 1.85e-04 | 63 | 169 | 5 | int:FAM9C | |
| Interaction | CCDC198 interactions | 2.04e-04 | 35 | 169 | 4 | int:CCDC198 | |
| Interaction | KRT26 interactions | 2.04e-04 | 35 | 169 | 4 | int:KRT26 | |
| Interaction | KRT5 interactions | 2.30e-04 | 193 | 169 | 8 | int:KRT5 | |
| Interaction | KRT82 interactions | 2.54e-04 | 37 | 169 | 4 | int:KRT82 | |
| Cytoband | 12q13 | 7.42e-06 | 71 | 172 | 5 | 12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 3.44e-05 | 423 | 172 | 9 | chr12q13 | |
| GeneFamily | Keratins, type II | 3.16e-10 | 27 | 117 | 7 | 609 | |
| GeneFamily | Actinins | 1.05e-06 | 4 | 117 | 3 | 1112 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.14e-06 | 13 | 117 | 4 | 685 | |
| GeneFamily | Myosin heavy chains | 1.14e-04 | 15 | 117 | 3 | 1098 | |
| GeneFamily | Dyneins, axonemal | 1.68e-04 | 17 | 117 | 3 | 536 | |
| GeneFamily | Ankyrin repeat domain containing | 1.79e-04 | 242 | 117 | 8 | 403 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.13e-03 | 8 | 117 | 2 | 939 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2 | KIF6 MYH10 GPX8 REV3L ODF2 DNAH7 CLHC1 TAFA2 TBC1D31 CEP112 TMCC1 PCM1 DNAH11 IQCG | 2.81e-06 | 471 | 171 | 14 | M3062 |
| Coexpression | GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN | 6.75e-06 | 199 | 171 | 9 | M6351 | |
| Coexpression | WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN | 8.78e-06 | 43 | 171 | 5 | M16646 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 1.12e-05 | 212 | 171 | 9 | M39221 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 1.56e-05 | 221 | 171 | 9 | M39222 | |
| Coexpression | FIGUEROA_AML_METHYLATION_CLUSTER_2_UP | 2.72e-05 | 54 | 171 | 5 | M2162 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MYH10 AHI1 MYO9A NAP1L1 DOCK10 CENPU REV3L SHTN1 SPECC1 LARP7 KIF15 CEP112 EXOC1 USP48 PCM1 | 2.81e-05 | 656 | 171 | 15 | M18979 |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 3.36e-05 | 137 | 171 | 7 | M39241 | |
| Coexpression | GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN | 4.28e-05 | 194 | 171 | 8 | M4687 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 8.89e-08 | 200 | 172 | 9 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-07 | 193 | 172 | 8 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-07 | 193 | 172 | 8 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-07 | 193 | 172 | 8 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-07 | 193 | 172 | 8 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-07 | 195 | 172 | 8 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-06 | 198 | 172 | 8 | b11d21aa96a0c91e958ae7ed8fd56546aeaebb91 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-06 | 198 | 172 | 8 | 605ef5b61750226b93bca48166d8a1f6450e80e0 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.14e-06 | 200 | 172 | 8 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | (3)_ILC|World / shred on Cell_type and subtype | 1.14e-06 | 200 | 172 | 8 | 03554b3f323785b1e0b48fa32de0d92065dd798e | |
| ToppCell | (30)_ILC|World / shred on Cell_type and subtype | 1.33e-06 | 204 | 172 | 8 | bd9fbd278c05e396463704d711b60d47699e3c09 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 5.65e-06 | 176 | 172 | 7 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.55e-06 | 184 | 172 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | COPD-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 8.39e-06 | 187 | 172 | 7 | be42ee71d3412bb1f52593d8814de85c354a0efa | |
| ToppCell | 367C-Endothelial_cells-Endothelial-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.39e-06 | 187 | 172 | 7 | 1342bc614bc4045263c2eb0a535a1dd6c64e7abe | |
| ToppCell | 367C-Endothelial_cells-Endothelial-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.39e-06 | 187 | 172 | 7 | 7aa206262b14b9f2aaa99e59da38b96c3594d2c9 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.39e-06 | 187 | 172 | 7 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.40e-06 | 123 | 172 | 6 | 511b7c20a4a85e49980936d52af7dbca19bb848e | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 8.99e-06 | 189 | 172 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.31e-06 | 190 | 172 | 7 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.31e-06 | 190 | 172 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.31e-06 | 190 | 172 | 7 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 9.96e-06 | 192 | 172 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.03e-05 | 193 | 172 | 7 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 1.03e-05 | 193 | 172 | 7 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.07e-05 | 194 | 172 | 7 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|World / Lineage, cell class and subclass | 1.07e-05 | 194 | 172 | 7 | 008bb0072f414a48d052429101bdc990ee4f80c2 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-05 | 194 | 172 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | proximal-Endothelial-Vein|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-05 | 195 | 172 | 7 | 0aebdd635a956dd2367883c1cf73d73ce9790635 | |
| ToppCell | proximal-3-Endothelial-Vein|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-05 | 195 | 172 | 7 | c81eb541c15b866f9b6ca6a5f1751c5f1243f4fb | |
| ToppCell | proximal-Endothelial-Vein-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-05 | 195 | 172 | 7 | df00f94facc5d6107aac83cef3c64fefc7f8e562 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.15e-05 | 130 | 172 | 6 | 8bd038b0423960ffdc6c8b128c46a55386f9c58c | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 197 | 172 | 7 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | COVID-19_Severe-PLT_0|COVID-19_Severe / Disease Group and Platelet Clusters | 1.18e-05 | 197 | 172 | 7 | dbdeefa72d10f2c5f75ad5aac6f31a892d4e94a9 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-05 | 198 | 172 | 7 | 1b9200e30f1d9b91bb0c6411c4f95208aedbe161 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-05 | 198 | 172 | 7 | 7e2d6e21b2b3d5a4a9f786890ec6ba2688a506cc | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-05 | 198 | 172 | 7 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-05 | 199 | 172 | 7 | 0075bcc7d2a5031e76a24cb176e16ac998d846fd | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.30e-05 | 200 | 172 | 7 | e6d36be0c4c569e27303bb4e4f34cd2187e9759d | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Macrophages|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.30e-05 | 200 | 172 | 7 | c0c51719cf81512c50bfcc2fed883c867e522d2a | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.30e-05 | 200 | 172 | 7 | 758840c31f2ddd7ccf7bf13252ebb48d33e89479 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.30e-05 | 200 | 172 | 7 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.30e-05 | 200 | 172 | 7 | c37fe06a94e5779c56e01389869bb432d3bbaebc | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.30e-05 | 200 | 172 | 7 | e663995fc44c340d878d66b278b7b5c2ff784301 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.30e-05 | 200 | 172 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 1.30e-05 | 200 | 172 | 7 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.30e-05 | 200 | 172 | 7 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-05 | 200 | 172 | 7 | e0cec0a844b7c1f8edee4c005af27766754e470a | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.30e-05 | 200 | 172 | 7 | 2cb8a39a12522a9643c6244d5e94cb4559868bb9 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.30e-05 | 200 | 172 | 7 | 8cc5057b0e5ae9b72ea40d2ffbc52b79bf87ccef | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-05 | 200 | 172 | 7 | cee07d9370656e1c428a7a9e9fbd175129901374 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7-Slc17a8.Syt6-Lancl3_(Cortical_Subplate_pyramidal_cells)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.34e-05 | 88 | 172 | 5 | fcc15c5c30517c63a835b28627c5f779d9bcd17e | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7-Slc17a8.Syt6-Lancl3_(Cortical_Subplate_pyramidal_cells)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.34e-05 | 88 | 172 | 5 | 7838c65160cf81c02b923fc34f566c0610c8d81b | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 3.23e-05 | 156 | 172 | 6 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 159 | 172 | 6 | 836c4b5f9a714ffb5a449087ebefdbb37dd3a2a9 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 159 | 172 | 6 | a6742ba2216427409173aec4e05a537d7fde226c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-05 | 162 | 172 | 6 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-05 | 162 | 172 | 6 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | droplet-Kidney-nan-21m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 164 | 172 | 6 | d4cdcd61e8c28b3fb912cef8837cc1a49678a729 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 164 | 172 | 6 | 1250876abd7311f86730e5b9c03c3610cc2ff6d3 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 164 | 172 | 6 | fa0d77b648cde5e42b9394e877168c80de238bde | |
| ToppCell | droplet-Kidney-nan-21m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 165 | 172 | 6 | c629ed33ff14834c32cc1a91116fb079f7aaa94d | |
| ToppCell | droplet-Kidney-nan-21m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 165 | 172 | 6 | 9852a4cb680af39c92c7d2d5e5fa8dc04e6602aa | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 166 | 172 | 6 | fc71e871084299fb6f006c76f91e72026a290149 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 166 | 172 | 6 | 13027ae342994db4540e64eb910df1f42b160931 | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 166 | 172 | 6 | 961f93f7fb127f449cb1021f6ba73775dc666c53 | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 166 | 172 | 6 | f55fc58572ae6080ac2758462a6b1f3f8b5a93f3 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 166 | 172 | 6 | b21e45bd43f26149b9cd6e45c19241c82d54fb2f | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 167 | 172 | 6 | f90cf0f29c14df4f211193326699e599ef955fa4 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 168 | 172 | 6 | 95416f352801ce42cc317565e7dfb00478c593e1 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.89e-05 | 168 | 172 | 6 | 937332580a522826b820e0b09080013f19f58479 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 168 | 172 | 6 | e979a4fbeb9f21048b47d69e6da75c57650697f2 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-neutrophil-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.89e-05 | 168 | 172 | 6 | b0376e3687fa85f091654196403eecedc219d0cd | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 169 | 172 | 6 | 972618e684321060c7af2429f853a6d639e8aae8 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 169 | 172 | 6 | 8e5e513090e86ca29fb61dfd388014774c506914 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 5.23e-05 | 170 | 172 | 6 | 97df5ffb328196c46568975d2d97722bcc753bf5 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM5|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.23e-05 | 170 | 172 | 6 | b2daf46ab5a49590ede8f75e4240bfe6e9d8b764 | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 171 | 172 | 6 | d6ae456e88ec49a8609a5e5e3af9f51921e66744 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-05 | 171 | 172 | 6 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 171 | 172 | 6 | d9ad6a3bce3556abd24af1630bf4a99594437c3a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-05 | 171 | 172 | 6 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.40e-05 | 171 | 172 | 6 | ed5886d6aa87b2d73469d39dc217227bd4d4c918 | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 171 | 172 | 6 | b3ea26d181f91ea07074f403e7dca9b6b671b1a2 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 172 | 172 | 6 | cfcfa7eeff1805bedf10a3c07826459914c3e872 | |
| ToppCell | droplet-Fat-Mat-18m-Lymphocytic-lymphocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 172 | 172 | 6 | 226de1a5d4a360d3ae01b0235fea19521ec623a0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.14e-05 | 175 | 172 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 6.33e-05 | 176 | 172 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 6.54e-05 | 177 | 172 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.54e-05 | 177 | 172 | 6 | 1cb78133ac09ea3a3f5b5de07151033998406512 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.74e-05 | 178 | 172 | 6 | 0b59e3d75b143bd7bf91a7800a49699c51e68c5a | |
| ToppCell | 3'_v3-Lung-Myeloid_Monocytic-Cycling_mono|Lung / Manually curated celltypes from each tissue | 6.74e-05 | 178 | 172 | 6 | 67aa17b17da3121c199af45e747c23e2626a9bb2 | |
| ToppCell | COPD-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 6.95e-05 | 179 | 172 | 6 | 9968da1adcb561d9bf167a42ab5d9de85c071c4a | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 6.95e-05 | 179 | 172 | 6 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.17e-05 | 180 | 172 | 6 | 5c9d2d44d840cd4ec7d42d43446ba2b689e7ec43 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.17e-05 | 180 | 172 | 6 | c60e74fbbd815a0251253a19dc520a254b2e1762 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.39e-05 | 181 | 172 | 6 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.62e-05 | 182 | 172 | 6 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.86e-05 | 183 | 172 | 6 | ce8be9418b473ea94ec806edc7a2078cc30c1703 | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 8.10e-05 | 184 | 172 | 6 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 8.10e-05 | 184 | 172 | 6 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| Drug | AC1L1BIT | 2.92e-07 | 60 | 168 | 7 | CID000001457 | |
| Drug | al-Badry | 4.27e-07 | 165 | 168 | 10 | CID000004545 | |
| Drug | sulfur mustard | 5.37e-07 | 130 | 168 | 9 | CID000010461 | |
| Drug | homocysteine thiolactone | 5.73e-07 | 131 | 168 | 9 | CID000107712 | |
| Drug | Bemegride [64-65-3]; Down 200; 25.8uM; PC3; HT_HG-U133A | ACACB DOCK9 REV3L ADAM10 HDAC7 PDE4DIP TLN2 TMCC1 TCTN1 IQCG | 2.25e-06 | 198 | 168 | 10 | 6668_DN |
| Drug | Propranolol hydrochloride [318-98-9]; Down 200; 13.6uM; MCF7; HT_HG-U133A | ARHGEF28 KRT83 DOCK9 DOCK10 HDAC7 FAN1 DNAH17 PDE4DIP ZNF639 IQCG | 2.25e-06 | 198 | 168 | 10 | 3396_DN |
| Drug | teleocidin B | 3.73e-06 | 123 | 168 | 8 | CID000072425 | |
| Drug | ATBI | 8.07e-06 | 18 | 168 | 4 | CID000505862 | |
| Drug | AC1L9MJT | 1.33e-05 | 192 | 168 | 9 | CID000448959 | |
| Drug | 4-aminoquinoline | 1.55e-05 | 21 | 168 | 4 | CID000068476 | |
| Drug | butyrate | MTA2 KRT72 KRT4 KRT5 MYH10 ACAT1 KRT34 KRT81 KRT82 KRT83 KRT86 REV3L HDAC7 MGAT5 TIMP2 POLR3E NFE2 TMCC1 | 1.57e-05 | 767 | 168 | 18 | CID000000264 |
| Drug | Phensuximide [86-34-0]; Up 200; 21.2uM; HL60; HT_HG-U133A | 1.70e-05 | 198 | 168 | 9 | 2960_UP | |
| Drug | Bretylium tosylate [61-75-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.77e-05 | 199 | 168 | 9 | 6674_DN | |
| Drug | pyriproxyfen | 2.27e-05 | 23 | 168 | 4 | CID000091753 | |
| Drug | formycin triphosphate | 3.68e-05 | 51 | 168 | 5 | CID000122274 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 4.66e-05 | 174 | 168 | 8 | 7530_DN | |
| Drug | melicopicine | 5.41e-05 | 2 | 168 | 2 | CID000101253 | |
| Drug | tebuquine | 5.41e-05 | 2 | 168 | 2 | CID000071991 | |
| Drug | 3,5-di-O-galloylquinic acid | 5.41e-05 | 2 | 168 | 2 | CID000460896 | |
| Disease | MONILETHRIX | 1.65e-07 | 3 | 163 | 3 | 158000 | |
| Disease | Beaded hair | 1.65e-07 | 3 | 163 | 3 | cv:C0546966 | |
| Disease | monilethrix (is_implicated_in) | 1.65e-07 | 3 | 163 | 3 | DOID:0050472 (is_implicated_in) | |
| Disease | Monilethrix | 6.59e-07 | 4 | 163 | 3 | C0546966 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 1.64e-06 | 5 | 163 | 3 | DOID:0111128 (implicated_via_orthology) | |
| Disease | hair disease (is_implicated_in) | 3.03e-05 | 2 | 163 | 2 | DOID:421 (is_implicated_in) | |
| Disease | EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE (disorder) | 9.07e-05 | 3 | 163 | 2 | C1832926 | |
| Disease | Dowling-Degos disease 1 | 1.81e-04 | 4 | 163 | 2 | C4552092 | |
| Disease | Reticulate acropigmentation of Kitamura | 1.81e-04 | 4 | 163 | 2 | C0406811 | |
| Disease | Heschl's gyrus morphology measurement | 2.13e-04 | 53 | 163 | 4 | EFO_0005852 | |
| Disease | dowling-degos disease | 3.00e-04 | 5 | 163 | 2 | C3714534 | |
| Disease | Epidermolysis Bullosa Simplex | 3.00e-04 | 5 | 163 | 2 | C0079298 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 6.25e-04 | 7 | 163 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | frontotemporal dementia | 7.30e-04 | 32 | 163 | 3 | MONDO_0017276 | |
| Disease | asthma, seasonal allergic rhinitis | 7.30e-04 | 32 | 163 | 3 | EFO_0003956, MONDO_0004979 | |
| Disease | alcohol-related neurodevelopmental disorder (implicated_via_orthology) | 8.31e-04 | 8 | 163 | 2 | DOID:0050667 (implicated_via_orthology) | |
| Disease | intelligence, specific language impairment, dyslexia | 8.31e-04 | 8 | 163 | 2 | EFO_0004337, EFO_0005424, EFO_1001510 | |
| Disease | chronic rhinosinusitis | 8.73e-04 | 34 | 163 | 3 | EFO_1000024 | |
| Disease | nasal disorder | 9.51e-04 | 35 | 163 | 3 | MONDO_0002436 | |
| Disease | asthma | AHI1 TCP11 RANBP6 ACTN3 HDAC7 BRAP MGAT5 FURIN UHRF2 NNMT GVQW3 SMAD3 | 9.96e-04 | 751 | 163 | 12 | MONDO_0004979 |
| Disease | anemia (phenotype), response to ribavirin | 1.06e-03 | 9 | 163 | 2 | EFO_0004272, GO_1901559 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.28e-03 | 215 | 163 | 6 | EFO_0008317, EFO_0008591 | |
| Disease | respiratory system disease | 1.29e-03 | 145 | 163 | 5 | EFO_0000684 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | alopecia areata (is_marker_for) | 1.33e-03 | 10 | 163 | 2 | DOID:986 (is_marker_for) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 1.62e-03 | 225 | 163 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | specific language impairment, dyslexia | 1.93e-03 | 12 | 163 | 2 | EFO_0005424, EFO_1001510 | |
| Disease | distal myopathy (implicated_via_orthology) | 1.93e-03 | 12 | 163 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.93e-03 | 12 | 163 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | plasma beta-amyloid 1-42 measurement | 2.27e-03 | 13 | 163 | 2 | EFO_0005660 | |
| Disease | cardiomyopathy (biomarker_via_orthology) | 2.27e-03 | 13 | 163 | 2 | DOID:0050700 (biomarker_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.27e-03 | 13 | 163 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 2.39e-03 | 48 | 163 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | neuroimaging measurement | KIF6 MYH10 PDE8A ANK3 DOCK9 ACTN4 REV3L SHTN1 STPG2 CEP112 FURIN MACF1 TLN2 DNAH11 | 2.52e-03 | 1069 | 163 | 14 | EFO_0004346 |
| Disease | Malignant neoplasm of breast | MYH1 KRT5 KIF6 CENPF UBR4 TAFA4 ADAM10 CXCL2 HDAC7 NLRC5 MACF1 PRDX5 PGBD3 AGAP2 | 2.62e-03 | 1074 | 163 | 14 | C0006142 |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.04e-03 | 15 | 163 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 3.46e-03 | 16 | 163 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | filaggrin gene expression measurement | 3.46e-03 | 16 | 163 | 2 | EFO_0020899 | |
| Disease | rhinitis | 3.91e-03 | 17 | 163 | 2 | EFO_0008521 | |
| Disease | adult onset asthma | 4.23e-03 | 118 | 163 | 4 | EFO_1002011 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.44e-03 | 276 | 163 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | hearing threshold measurement, hearing measurement | 4.71e-03 | 61 | 163 | 3 | EFO_0007616, EFO_0007618 | |
| Disease | Chronic myeloproliferative disorder | 4.88e-03 | 19 | 163 | 2 | C1292778 | |
| Disease | cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant | 4.88e-03 | 19 | 163 | 2 | EFO_0007044, EFO_0020106 | |
| Disease | atopic asthma | 5.07e-03 | 199 | 163 | 5 | EFO_0010638 | |
| Disease | urinary microalbumin measurement | 5.40e-03 | 20 | 163 | 2 | EFO_0010967 | |
| Disease | Familial aplasia of the vermis | 5.40e-03 | 20 | 163 | 2 | cv:C0431399 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QKECNKEKNRNSSVV | 1171 | P23470 | |
| RASQVVKDCVKACLN | 991 | Q9UPW8 | |
| QDSVRQARKEAVCKI | 431 | O95429 | |
| VILQCQRDSEKNKEQ | 71 | Q5JX71 | |
| IKNCKVLTIVEASVN | 111 | Q96RT1 | |
| KQSVERKCTQLNTKV | 466 | Q7Z569 | |
| CQKVCKEAALSQEQI | 621 | O14867 | |
| GAQKAETAANRICKV | 251 | P12814 | |
| ETAANRICKVLAVNQ | 256 | P12814 | |
| CNILVKTNGSEQEVK | 61 | Q6UXZ3 | |
| VTEVIRSCAAKVNKN | 986 | Q8N157 | |
| SQVLEKKRNNCFVES | 441 | O14672 | |
| QKVKDLVCSNRQLTV | 76 | Q3ZCU0 | |
| AQKAETAANRICKVL | 271 | O43707 | |
| TAANRICKVLAVNQE | 276 | O43707 | |
| QQRIESKVCKAAIAT | 266 | Q71F23 | |
| ENRSNQVRCAEKKLQ | 876 | Q8N8E3 | |
| KESQAQRQKISRCQV | 1671 | P53420 | |
| NDIKCEAQQELRTVK | 736 | Q5M775 | |
| EKVRCQEEVNQTNKT | 3361 | Q96DT5 | |
| IKAACLVQQKRQEFL | 711 | Q9P2G1 | |
| VVTLRKQQQLLAACK | 566 | Q99490 | |
| NCKNRVVQSGIKVRL | 1026 | Q96KQ7 | |
| VQRDLSQTQCQKKET | 816 | Q8IYA2 | |
| QACQADRQKTKETLQ | 186 | P21854 | |
| DKCQKLQTALAIAEN | 321 | Q8NB25 | |
| ELKQDNIAVKANAVC | 46 | O14617 | |
| QIAQTQKKCNRTEEL | 276 | Q9H095 | |
| QKTRQKAQELAVSTC | 41 | Q6ZS82 | |
| NKTANGNVEAKVVCL | 31 | O94776 | |
| AFVQCARKILNKIES | 166 | P20338 | |
| RRVNALKNLQVKCAQ | 76 | P55209 | |
| DNKKRTALIKAVQCQ | 166 | H3BUK9 | |
| SILKEAQIKVNQCDR | 301 | Q86VD1 | |
| EKVLIANNGIAAVKC | 261 | O00763 | |
| RKAEARVAKIQQCQE | 1206 | Q8N1W1 | |
| TKNVEKACQLINRQD | 1526 | Q9NRD9 | |
| ISKRKCEAANVAEQR | 166 | P17693 | |
| NTIEDLQQKILCTKA | 141 | Q6A162 | |
| IVKCTDNKRENLNEV | 171 | Q7Z3D4 | |
| ATKACKRQEVSQLNK | 636 | Q9NS87 | |
| KINVADIINGAQEKC | 131 | Q09328 | |
| QRKIDQRICNAITKS | 306 | Q9NXD2 | |
| EVQAAFVKLKQLCVN | 341 | Q9NXD2 | |
| NKKFIIANARVQNCA | 26 | Q9NS40 | |
| KQIKVAQALCEDLSA | 4791 | Q03001 | |
| KNCANEAVVQKILDR | 51 | Q9UN88 | |
| LRAEIDNVKKQCANL | 396 | P13647 | |
| RLTAEVENAKCQNSK | 331 | O43790 | |
| VENAKCQNSKLEAAV | 336 | O43790 | |
| RAEIENIKKQCQTLQ | 366 | P19013 | |
| AKRICKDLENLSQIQ | 486 | O95786 | |
| ACENARLKAQQIKEE | 311 | Q5BJE1 | |
| KREEIANACNAVIQK | 296 | Q6NT76 | |
| QDLDNNSITVKQRCK | 1691 | Q15154 | |
| SIIRVCNGNNKAEKI | 321 | O60658 | |
| LRQAVKQVLKCDVTQ | 131 | P40261 | |
| VILQCQRDSEKNKEQ | 71 | Q5JX69 | |
| SEKAAVEFNKQVCIA | 156 | Q5T1M5 | |
| AVINKSSRRVDQEKC | 301 | Q12986 | |
| IAFIKARQSILQKQC | 796 | Q6ZMV9 | |
| QVAQCKCAKRFQVEQ | 3256 | O94854 | |
| KTANREECRTQEKVN | 431 | Q4G0J3 | |
| LQQETENVKAQRCKL | 346 | Q9NSB4 | |
| VERTNAACAALDKKQ | 1436 | P12882 | |
| KQLNENQVRTLCEKA | 21 | P62714 | |
| DCVGAKQAAVVQVLK | 586 | Q86WI3 | |
| QAEALKAKGVQVVAC | 111 | P30044 | |
| KAKGVQVVACLSVND | 116 | P30044 | |
| RVNQLFAQAKACKVL | 111 | Q96NT3 | |
| QTAAREQAKEACKAA | 746 | Q01780 | |
| ACKAAAEQAISVRQQ | 756 | Q01780 | |
| RVCFKKNCVNSSVLQ | 616 | Q9UKF2 | |
| EKAQIAAAKEICQAI | 371 | Q9P2D3 | |
| QTEVIATLKNGQKAC | 71 | P19875 | |
| KVNALQAQVCELQKE | 346 | Q9BXL6 | |
| CIQKAQDAEKRTAVQ | 431 | Q8NCX0 | |
| SQKCFNKARNITVCI | 686 | Q96BY6 | |
| NKARNITVCIEFKNS | 691 | Q96BY6 | |
| NVIVQKKTQILNDCL | 56 | Q9BZ29 | |
| KVCVNEEGIQKLQRA | 136 | O15228 | |
| QNAESARCSLEQKIK | 376 | P49454 | |
| EKIKCQQEADATNRV | 3306 | Q9UFH2 | |
| AEQLKNQIRDARKAC | 11 | P62873 | |
| VQQLSLASLCVKKQQ | 191 | Q8NFT6 | |
| CVEQKTDALGKQSVN | 121 | Q5TC12 | |
| QNEKQIVTTDLRQKC | 346 | P09958 | |
| AEQVAAVKRVKQCKD | 96 | Q9NXW2 | |
| DSCVNIQKAIKGLAV | 3801 | Q8WXX0 | |
| QSSCKAKVANIIAEV | 61 | P52306 | |
| DNIIAVRKACATQKQ | 3921 | Q12955 | |
| KVCRKQQVAAVDQSE | 491 | Q99741 | |
| ARKAVEATQVCRTNK | 361 | O43462 | |
| VKLQRQQVSKCSEEI | 26 | P61952 | |
| VTVKRNFDKCISNQI | 641 | Q9NV70 | |
| TNEICAIQENSKLKR | 101 | O60676 | |
| LQVKQQLDSCVTKCV | 101 | Q96C01 | |
| AIACRQLQQQSKASK | 686 | Q8WUI4 | |
| NKAAKTQLAVCQQRI | 386 | Q02790 | |
| DQCIQKLQAEVKASQ | 136 | P0DO97 | |
| ERVQRDLSQTQCQKK | 1001 | A2RUR9 | |
| KGKVSLVVNVASDCQ | 66 | Q8TED1 | |
| ANDVIQNCKRKNAII | 81 | Q5VT52 | |
| TKTVQQKACAEVIKQ | 321 | Q9BZW2 | |
| CGDQRIQVAKTKAQQ | 456 | Q9NVU0 | |
| RLASKNCVVKNLEAV | 361 | P20648 | |
| TDNKELACEVKVLQQ | 1231 | P35580 | |
| LACEVKVLQQVKAES | 1236 | P35580 | |
| KTNQVAIAQTLECKE | 261 | Q9UK39 | |
| RLTAEVENAKCQNSK | 336 | P78385 | |
| VENAKCQNSKLEAAV | 341 | P78385 | |
| CEIEIKKSNSVQEQR | 466 | P42702 | |
| ENRERTANENKKTIC | 306 | Q3MIW9 | |
| NKVAAQNCRKRKLET | 276 | Q16621 | |
| LLQEIQCEKAQAKTA | 321 | Q5BJF6 | |
| INHVIVKQGKQTRCA | 551 | Q8N328 | |
| DQQTVKLVCTNRRKQ | 666 | Q8IWE5 | |
| DVCKRQRKTLQDNQL | 31 | Q8TBY8 | |
| CKNQDELRNRSVKVI | 136 | Q9Y2M0 | |
| RCCNKNKIEERSQTV | 51 | Q8N3H0 | |
| CCNKNRIEERSQTVK | 61 | Q96LR4 | |
| RAQCAIKQTQVTVQK | 201 | Q9P2Y5 | |
| VIKENLAKAEQACLN | 881 | Q96DN5 | |
| EKNCQNKCRIALVEN | 101 | Q8N7P1 | |
| QQKILCAKAENARLV | 156 | O76011 | |
| DNKKRTALIKAVQCQ | 166 | A0A0A6YYL3 | |
| SRIAAQAVTKNCQKA | 36 | Q8NHV1 | |
| DNKKRTALTKAVQCQ | 166 | P0CG39 | |
| AAETCVSVQCQKQIK | 131 | A0MZ66 | |
| VSVQCQKQIKELRDQ | 136 | A0MZ66 | |
| VERSNAACIALDKKQ | 1436 | Q9Y623 | |
| CAENTAKKLNIARNE | 196 | P24752 | |
| RKVNQKIGSCTQQDV | 121 | P14868 | |
| SRNCTKNGIVKEAQQ | 26 | Q9NUV7 | |
| DRNKKCRQSVNVESI | 231 | Q9NWQ8 | |
| LVVECQQERSQIKNK | 331 | O75570 | |
| KKNVIATENCISAIG | 971 | O60518 | |
| TAANRICKVLAVNQE | 271 | Q08043 | |
| NVTCEKEKLLERQQQ | 431 | Q96JN2 | |
| SKIQSQIDHIKQCRA | 131 | Q8NHS4 | |
| NINLVTQKKARFVCV | 131 | Q9Y271 | |
| KNDCQRIEKQRASDT | 6 | Q5SQS8 | |
| QSQVKIVKNTDGREC | 86 | Q8N9Z0 | |
| NKKRESNCLVERSNQ | 26 | Q537H7 | |
| NVCKDCLQRSFKAQV | 751 | Q96PU4 | |
| QLQNIAKKENCVCSV | 411 | Q8WWU5 | |
| AKKENCVCSVIDQRI | 416 | Q8WWU5 | |
| GVCVKQHKRLTQAIQ | 141 | Q9Y676 | |
| SKNVQRLVKEACTHN | 421 | A4D1E1 | |
| RVQAKKCQEQSSNVE | 931 | A4D1E1 | |
| NQVKVKVTCALGSNA | 531 | Q5T7W0 | |
| ELQVLVKVNGVQSCK | 96 | P0CG00 | |
| CKILDKSQALNVTAQ | 176 | Q9UID6 | |
| IKNCIAQTSAVVKNL | 71 | Q4VC31 | |
| ERQQEQLVKICKNCT | 3076 | O60673 | |
| CTSVNLNKACRKQEE | 751 | Q8WYR1 | |
| LEKAITTQNVNTKCI | 51 | P84022 | |
| AQVAKAVTQALNRCV | 1186 | Q9Y490 | |
| NNTIIASVRNICSKK | 266 | Q8N412 | |
| AKIKAVQRSGCNEVT | 201 | Q6FHJ7 | |
| EQQRISKDLANICKT | 66 | Q9NPL8 | |
| QVLVKVNGVQSCKDL | 101 | A6NJL1 | |
| RSNLVQVKVEKEASC | 266 | Q99592 | |
| VNQAVKCTRKINLEQ | 241 | Q2MV58 | |
| QAFCNADVVIRAKAV | 36 | P16035 | |
| ANSADKQQAARIKQV | 266 | O94876 | |
| TLAQNIRKFVEEVKC | 1231 | Q70Z35 | |
| VLKAKVQCELNITAQ | 41 | P49190 | |
| AQCIQKNVAVFLAVK | 1366 | Q8IUG5 | |
| TAAKKQTLCLQAQRE | 586 | Q641Q2 | |
| QTLCLQAQREEKAKA | 591 | Q641Q2 | |
| TQEKVCRNEEQLISK | 711 | Q9HCJ5 | |
| TAQLLVACKVKADQD | 2436 | Q9Y4G6 | |
| VIKKILQSNDCIEAA | 81 | Q4G0G5 | |
| KENKNVTALEACALQ | 986 | Q5T4S7 | |
| IVCAAVITRQKQKAS | 111 | Q4V9L6 | |
| ENCQSKQNATRKIRL | 271 | Q86UV5 | |
| NKKRTALTKAVQCQE | 241 | Q6S545 | |
| CTIQQLKEEISQRFK | 41 | Q9H347 | |
| QCVETLQKQTRVGKA | 376 | Q8N5A5 | |
| EINTQKISRCQECQK | 216 | P17097 | |
| LILNVQVQRKCTQDK | 276 | Q96MR9 | |
| QRIRSEIGNVKKQCA | 351 | Q14CN4 | |
| RLTAEVENAKCQNSK | 331 | Q14533 | |
| VENAKCQNSKLEAAV | 336 | Q14533 | |
| NVACKLSNNRISKRE | 1631 | B2RTY4 | |
| VVRQKERQLADAKQC | 361 | Q5VU43 |